RNA AVIDITY BIOSCIENCES INC

Ownership history in XTX Topco Ltd  ·  8 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2023 Q3)
Avg. % of fund
0.04%
First filed
2022 Q3
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 15,652 +6,763 +76.1% 0.04% $682K
2024 Q4 ADDED 8,889 +2,852 +47.2% 0.02% $258K
2024 Q3 REDUCED 6,037 -4,018 -40.0% 0.02% $277K
2024 Q1 REDUCED 10,055 -50,676 -83.4% 0.03% $257K
2023 Q3 ADDED 60,731 +47,812 +370.1% 0.07% $387K
2023 Q1 ADDED 12,919 +1,857 +16.8% 0.04% $198K
2022 Q4 ADDED 11,062 +924 +9.1% 0.05% $245K
2022 Q3 INITIATED 10,138 0.04% $166K
% of Fund (quarterly)    RNA price (monthly, adj. close)
← Back to XTX Topco Ltd Holdings